Introduction {#s1}
============

Histone posttranslational modifications (PTMs) play a crucial role in regulating a wide range of biological processes, such as gene transcription, DNA replication, and chromosome segregation ([@bib18]). Increasing evidence has indicated that PTMs of histones can serve as a heritable 'code' (so-called 'histone code'), which provides epigenetic information that a mother cell can pass to its daughters ([@bib15]). Histone code is 'written' or 'erased' by enzymes that add or remove the modifications of histones ([@bib8]; [@bib18]). Meanwhile, 'readers' of histone code recognize specific histone modifications and 'translate' the code by executing distinct cellular programs necessary to establish diverse cell phenotypes, while the genetic code (DNA) is unaltered ([@bib30]; [@bib36]).

Lysine acetylation (Kac) was among the first covalent modification of histones to be described ([@bib1]; [@bib2]). Since its identification, histone Kac has been correlated with gene expression. However, the mechanistic insights into the regulation and functions of histone Kac remained challenging and elusive, until the identification and characterization of the enzymes responsible for the addition and removal of this PTM, which are now known as histone acetyltransferases ([@bib27]) and deacetylases ([@bib28]; [@bib39]; [@bib10]), respectively. Extensive studies have now revealed that Kac plays an important role in controlling chromatin structure and gene transcription ([@bib9]; [@bib40]). By neutralizing positively charged lysine residues, acetylation alters the coulumbic interactions between basic histones and the negatively charged DNA, and thereby influences the structure of chromatin compaction ([@bib38]; [@bib32]). In addition, acetylation may serve as a docking site for 'reader' proteins (e.g., bromodomain containing proteins), which are recruited onto chromatin to carry out downstream cellular processes, such as gene transcription ([@bib4]; [@bib23]; [@bib42]).

Lysine crotonylation (Kcr) is a newly discovered histone PTM that is specifically enriched at active gene promoters and potential enhancers in mammalian cell genomes ([@bib33]). In postmeiotic male germ cells, Kcr specifically marks testis specific X-linked genes, suggesting it is likely that it is an important histone mark for male germ cell differentiation. However, further mechanistic and functional studies of histone Kcr have been limited by a lack of knowledge of the enzymes that catalyze the addition or removal of Kcr in cells. In a systematic screening of the activities of the 11 human zinc-dependent lysine deacetylases (i.e., HDAC1--HDAC11) against a series of C-terminal lysine acylated peptides, Olsen et al. found that HDAC3 in complex with nuclear receptor corepressor 1 (HDAC3--NCoR1) had detectable decrotonylase activity towards a model peptide substrate in a fluorometric assay ([@bib22]). Recently, using a radioactive thin layer chromatography based assay, Denu et al. demonstrated that Sirt1 and Sirt2 can catalyze the removal of a crotonyl group from a histone H3K9Cr peptide ([@bib6]). However, this discovery was based on a single peptide substrate. Due to lack of further characterization of these identified enzymes, their mechanisms of catalysis and the molecular bases of substrate recognition remain unclear. More importantly, since both discoveries relied on peptide based in vitro screening assays, there is still an essential need to identify endogenous histone decrotonylases.

To fill this knowledge gap, a method to profile 'eraser' enzymes that recognize Kcr is needed. A Cross-Linking Assisted and Stable isotope labeling of amino acids in cell culture (SILAC) based Protein Identification (CLASPI) approach has recently been reported to identify histone PTM 'readers' ([@bib21]; [@bib20]). However, this approach has not previously been explored to identify histone PTM 'erasers', which are likely involved in weak and transient interactions. Here we present the application of an optimized CLASPI approach to comprehensively profile 'eraser' enzymes that recognize histone Kcr marks. We identified human Sirt1, Sirt2, and Sirt3 as decrotonylases in vitro and examined the molecular basis for how the enzymes recognize Kcr using X-ray crystallography. Furthermore, we demonstrated that Sirt3 can function as an 'eraser' enzyme to regulate histone crotonylation dynamics in living cells.

Results {#s2}
=======

Chemical proteomics approach to profile proteins recognizing histone H3K4Cr mark {#s2-1}
--------------------------------------------------------------------------------

We first focused on a crotonylation mark discovered on histone H3K4 ([@bib33]). We designed a peptide probe (probe **1**, [Figure 1A](#fig1){ref-type="fig"}) to convert non-covalent protein--protein interactions mediated by this Kcr into irreversible covalent linkages through photo-cross-linking. The probe is based on the unstructured N-terminal region of histone H3, with lysine-4 crotonylated, a photo-cross-linker (benzophenone) appended to alanine-7, and a bio-orthogonal handle (alkyne) at the peptide C terminus to enable selective isolation of captured binding partners. To identify proteins that bind H3K4Cr with high selectivity and high affinity, we performed two types of CLASPI experiments with cell lysates derived from HeLa S3 cells grown in medium containing either 'heavy' (^13^C, ^15^N-substitued arginine and lysine) or 'light' (natural isotope abundance forms) amino acids ([Figure 1B](#fig1){ref-type="fig"}).10.7554/eLife.02999.003Figure 1.Cross-Linking Assisted and SILAC based Protein Identification (CLASPI) strategy.(**A**) Chemical structures of probe **1** and probe **C**. (**B**) Schematic diagram illustrating the CLASPI strategy to profile proteins that bind H3K4Cr with high selectivity and affinity in whole-cell proteomes. LC-MS, liquid chromatography--mass spectrometry.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.003](10.7554/eLife.02999.003)

In a 'selectivity filter' CLASPI experiment, the 'heavy' and 'light' cell lysates were photo-cross-linked with probe **1** and an unmodified H3 control probe (probe **C**, [Figure 1A](#fig1){ref-type="fig"}), respectively, and pooled for the subsequent steps. The captured proteins were then conjugated to biotin using click chemistry, followed by affinity purification, gel electrophoresis, and in-gel trypsin digestion. The digested peptide mixtures were separated by high performance liquid chromatography (HPLC) and analyzed with a LTQ-Orbitrap mass spectrometer. Using this method, proteins that show a high SILAC ratio of heavy/light (H/L) are likely H3K4Cr selective binders. To further distinguish the high affinity interactions, we performed an 'affinity filter' CLASPI experiment, in which both lysates were photo-cross-linked with probe **1** but the 'light' sample also contained H3K4Cr peptide as a competitor (30 μM) ([Figure 1B](#fig1){ref-type="fig"}). We expected that the addition of the competitor peptide in the 'light' lysate would effectively inhibit **1**-induced cross-linking of H3K4Cr binders that have high affinity (*K*~d~ \< 30 μM) towards the H3K4Cr peptide, and should thereby produce a high SILAC ratio of H/L for these proteins. Together, we consider a protein as a selective and tight binder of H3K4Cr when it shows high SILAC ratios of H/L in both 'selectivity filter' and 'affinity filter' experiments ([Figure 2---source data 1](#SD1-data){ref-type="supplementary-material"}).

Sirt1, Sirt2, and Sirt3 recognize histone H3K4Cr mark {#s2-2}
-----------------------------------------------------

A two-dimensional plot with logarithmic (Log~2~) SILAC ratios of H/L of the identified proteins in the 'selectivity filter' and 'affinity filter' experiments, along the x axis and y axis, respectively, is shown in [Figure 2A](#fig2){ref-type="fig"}. As expected, the majority of identified proteins did not show significant differences between the signal intensities of their 'heavy' and 'light' forms (i.e., H/L close to 1:1), suggesting they are not likely to be H3K4Cr binding proteins. In contrast, three nicotinamide adenine dinucleotide (NAD)-dependent deacetylases ([@bib13]; [@bib19]; [@bib28]), Sirt1, Sirt2, and Sirt3, were enriched by more than 10-fold by the K4 crotonylated probe (**1**) in the 'selectivity filter' experiment ([Figure 2A, B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), indicating that they preferentially bind to this histone Kcr mark. However, among these three selective H3K4Cr binders, only Sirt3 showed the highest SILAC ratio of H/L and thereby appeared as an outlier outside of the background in the 'affinity filter' experiment ([Figure 2A, B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). This result indicates that Sirt3 is likely a selective and relatively tight binding partner of H3K4Cr.10.7554/eLife.02999.004Figure 2.Identification of Sirt3 as a selective and tight binding partner of lysine-4 crotonylated histone H3.(**A**) A two-dimensional plot showing the Log~2~ values of the stable isotope labeling of amino acids in cell culture (SILAC) ratios (heavy/light (H/L)) of each identified protein for the 'selectivity filter' (x axis) and 'affinity filter' (y axis) experiments. (**B**) Representative mass spectrometry (MS) spectra of a peptide, ^225^LYTQNIDGLER^235^, from Sirt3 identified in both the 'selectivity filter' and 'affinity filter' experiments. The 'light' and 'heavy' peptide isotopes are indicated by blue and red dots, respectively. (**C**) Recombinant Sirt3 was selectively labeled in vitro by crotonylated probe **1** (2 μM) and the labeling by probe **1** was inhibited by a H3K4Cr peptide (30 μM). (**D**) Determination of IC~50~ for inhibition of probe **1** induced labeling of Sirt3 by H3K4Cr peptide (n=3, mean±s.e.). (**E**) Isothermal titration calorimetry measurement for the binding affinity of Sirt3 towards the H3K4Cr peptide.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.004](10.7554/eLife.02999.004)10.7554/eLife.02999.005Figure 2---source data 1.Proteins quantified in the 'selectivity filter' and 'affinity filter' Cross Linking Assisted and SILAC based Protein Identification (CLASPI) experiments.Proteins are sorted according to their ratio in the 'selectivity filter' experiment. Known contaminants such as keratin are not included.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.005](10.7554/eLife.02999.005)10.7554/eLife.02999.006Figure 2---figure supplement 1.Representative mass spectrometry spectra for peptides from Sirt1 and Sirt2.Representative mass spectrometry spectra for peptides from Sirt1 (**A**) and Sirt2 (**B**), identified in both 'selectivity filter' and 'affinity filter' Cross Linking Assisted and SILAC based Protein Identification (CLASPI) experiments. The 'light' and 'heavy' peptide isotopes are indicated by blue and red dots, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.006](10.7554/eLife.02999.006)10.7554/eLife.02999.007Figure 2---figure supplement 2.ITC measurement for the binding affinity of Sirt1-3 toward H3K4Cr peptide.(**A**--**C**) Isothermal titration calorimetry measurement for the binding affinities of Sirt1 (**A**), Sirt2 (**B**), and Sirt3 (**C**) towards H3K4Cr. (**D**) A summary of the dissociation constants (*K*~d~), enthalpy changes (Δ*H*), and andentropy changes (Δ*S*) of Sirt1, Sirt2, and Sirt3 binding to H3K4Cr.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.007](10.7554/eLife.02999.007)

We next examined whether Sirt3 can directly and selectively bind to this crotonylated histone peptide in vitro. As shown in [Figure 2C](#fig2){ref-type="fig"}, the recombinant Sirt3 was captured by probe **1** but not by probe **C**, and the cross-linking was competed by the H3K4Cr peptide with an IC~50~=32.3 μM ([Figure 2D](#fig2){ref-type="fig"}), verifying a direct and selective interaction between Sirt3 and the K4 crotonylated H3 peptide. Indeed, the direct measurement of binding affinity using isothermal titration calorimetry showed that Sirt3 bound to the H3K4Cr peptide with *K*~d~=25.1 μM ([Figure 2E](#fig2){ref-type="fig"}). Consistent with our 'affinity filter' CLASPI analysis, Sirt1 and 2 showed lower affinities towards the H3K4Cr peptide ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), indicating that they are selective but relatively weak binders towards this histone Kcr mark.

Molecular basis for how Sirt3 recognizes histone Kcr {#s2-3}
----------------------------------------------------

To study the molecular basis for the recognition of H3K4Cr by Sirt3, we determined the crystal structure of human Sirt3 in complex with an H3K4Cr peptide to 2.95 Å resolution (PDB 4V1C). The asymmetric unit consists of six molecules, each containing one Sirt3--H3K4Cr complex. The two globular domains of Sirt3 composed of an NAD binding Rossmann fold and a zinc binding motif are similar to other sirtuins ([Figure 3A](#fig3){ref-type="fig"}) ([@bib3]; [@bib5]; [@bib41]; [@bib16]). Residues ^2^RTKQTAR^8^ of the H3K4Cr peptide were clearly identified based on electron density. The way that the substrate is bound is similar to the published complex structure of Sirt3, with a lysine acetylated AceCS2 peptide (PDB 3GLR) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) ([@bib17]). The crotonyl lysine is located in a binding pocket formed by hydrophobic residues Phe180, Ile230, His248, Ile291, and Phe294 of Sirt3 ([Figure 3B](#fig3){ref-type="fig"}). Residue His248, a catalytic residue for the deacetylation activity of Sirt3, interacts with the crotonyl amide oxygen via hydrogen bonding in the structure ([Figure 3B](#fig3){ref-type="fig"}). Strikingly, the phenyl ring of residue Phe180 aligns parallel to the planar crotonyl group and has a short distance of 3.6 Å to its conjugated carbon--carbon double bond (C=C) ([Figure 3C, D](#fig3){ref-type="fig"}), indicating a robust π-π stacking interaction between the two functional groups. Interestingly, a primary sequence alignment of all sirtuins revealed that the phenylalanine residue (Phe180) of Sirt3 is conserved in Sirt1 and Sirt2, but not in other sirtuins ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), which may explain why Sirt4--Sirt7 were not identified in our CLASPI experiments. This π-π interaction therefore underlies the mechanism for the recognition of crotonyl lysine by Sirt1, Sirt2, and Sirt3.10.7554/eLife.02999.008Figure 3.Structural basis for how Sirt3 recognizes lysine crotonylation.(**A**) Overall structure of the complex of Sirt3 (gray) with H3K4Cr peptide (green). (**B**) The binding pocket formed by hydrophobic residues (orange) that accommodate the crotonyl lysine. A side view (**C**) and top view (**D**) of a π-π stacking interaction between residue Phe180 of Sirt3 and the crotonyl group.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.008](10.7554/eLife.02999.008)10.7554/eLife.02999.009Figure 3---figure supplement 1.Detailed structural analysis for Sirt3 in complex with H3K4Cr peptide.(**A**) Structural alignment between the Sirt3--AceCS2 complex colored in cyan (PDB 3GLR) and the Sirt3--H3K4Cr complex colored in orange. (**B**) Interactions between Sirt3 and H3K4Cr peptide. The residues of Sirt3 are colored in yellow and H3K4Cr peptide is colored in green.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.009](10.7554/eLife.02999.009)10.7554/eLife.02999.010Figure 3---figure supplement 2.Sequence alignment of human Sirt1--Sirt7.The included sequences are Sirt1-197-542 (full length, 747 amino acids (a.a.)), Sirt2-54-370 (389 a.a.), Sirt3-107-391 (399 a.a.), Sirt4-31-312 (314 a.a.), Sirt5-20-305 (310 a.a.), Sirt6-20-305 (355 a.a.), and Sirt7-71-347 (400 a.a.). The residues of Sirt3 that interact with crotonyl lysine in the crystal structure of the Sirt3--H3K4Cr complex are indicated (▼) above the residues and labeled with the Sirt3 sequence number. Highlighted in green is the Phe180 of Sirt3, which is involved in recognition of the crotonyl lysine via a π−π stacking interaction, and is conserved in Sirt1 and Sirt2, but not in the other sirtuins. The alignment was done by T-coffee (Notredame C, Higgins DG, and Heringa, J. 2000, Journal of Molecular Biology 302, 205--17).**DOI:** [http://dx.doi.org/10.7554/eLife.02999.010](10.7554/eLife.02999.010)

Sirt1, Sirt2, and Sirt3 catalyze hydrolysis of crotonylated histone peptides in vitro {#s2-4}
-------------------------------------------------------------------------------------

Inspired by the fact that Sirt3 binds crotonyl lysine at its catalytic pocket that is known for hydrolysis of acetyl lysine, we next tested whether Sirt3 has decrotonylation activity. Liquid chromatography--mass spectrometry (LC-MS) was used to monitor hydrolysis of the H3K4Cr peptide by Sirt3. As expected, Sirt3 efficiently catalyzed the hydrolysis of the crotonyl peptide only in the presence of NAD ([Figure 4A](#fig4){ref-type="fig"}), suggesting an NAD-dependent decrotonylation mechanism. The steady state kinetic analysis revealed that the *k*~cat~, *K*~m~, and *k*~cat~/*K*~m~ for Sirt3 catalyzed decrotonylation of H3K4Cr were 0.010 s^−1^, 12.6 μM, and 783 s^−1^ M^−1^, respectively ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In addition, we detected *O*-crotonyl-adenosine 5ʹ-diphosphoribose (*O*-Cr-ADPR) as a product of this hydrolysis reaction ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). A mutation of the catalytic residue (H248Y) that is crucial for the deacetylation activity of the enzyme also completely abolished its decrotonylation activity ([Figure 4C](#fig4){ref-type="fig"}). These data indicate that Sirt3 hydrolyzes crotonyl lysine with the same mechanism as it hydrolyzes acetyl lysine ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}) ([@bib34]; [@bib35]). In addition to H3K4Cr, we also examined the activity of Sirt3 to hydrolyze a collection of crotonyl histone peptides ([@bib33]). As shown in [Figure 4D--G](#fig4){ref-type="fig"}, Sirt3 manifested varied decrotonylation activities towards these peptides and this substrate selectivity can be partially explained by the binding affinities of Sirt3 to these peptides ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). The observation that Sirt3 binds a crotonylated peptide by recognizing both the modification site and its surrounding residues was also supported by the extensive hydrophobic and hydrogen bonding interactions between Sirt3 and the peptide side chains in the Sirt3--H3K4Cr complex structure ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).10.7554/eLife.02999.011Figure 4.Sirt3 catalyzes the hydrolysis of crotonyl lysine in vitro.(**A**--**C**) The hydrolysis of the crotonylated peptides by Sirt3 was analyzed by liquid chromatography--mass spectrometry. The hydrolysis of H3K4Cr was observed with Sirt3 in the presence (**A**), but not absence of nicotinamide adenine dinucleotide (NAD) (**B**), or with the mutated Sirt3, H248Y (**C**). (**D**--**G**) Sirt3 showed varied decrotonylation activities towards H2BK5Cr (**D**), H3K9Cr (**E**), H3K27Cr (**F**), and H4K8Cr (**G**) peptides. Black traces show total ion intensity for all ion species with *m*/*z* from 300 to 2000 (i.e., total ion counts, TIC); pink traces show ion intensity (5× magnified) for the masses of decrotonylated (unmodified) peptides; and blue traces show ion intensity (5× magnified) for the masses of crotonylated peptides.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.011](10.7554/eLife.02999.011)10.7554/eLife.02999.012Figure 4---figure supplement 1.Michaelis--Menten plots showing the kinetics of Sirt3 and mutant Sirt3 (F180L) decrotonylation on H3K4Cr.The enzyme concentrations and reaction times were used as indicated in 'Materials and methods'. For kinetic parameters, values are reported as mean ± s.e. (n=3).**DOI:** [http://dx.doi.org/10.7554/eLife.02999.012](10.7554/eLife.02999.012)10.7554/eLife.02999.013Figure 4---figure supplement 2.Detection of *O*-crotonyl-adenosine 5ʹ-diphosphoribose (*O*-Cr-ADPR) by liquid chromatography--mass spectrometry (LC-MS).The reaction mixture of Sirt3 catalyzed nicotinamide adenine dinucleotide (NAD) dependent decrotonylation of H3K4Cr peptide was analyzed by LC-MS. Partial chromatogram of the reaction mixture with UV (260 nm) (**A**) and mass detector (**B**). In (**B)**, the black trace shows total ion intensity for all ion species with *m*/*z* from 300 to 2000 (i.e., total ion counts, TIC); blue trace shows ion intensity (5× magnified) for the mass of NAD (*m*/*z* = 664); and pink trace shows ion intensity (5× magnified) for the mass of O-Cr-ADPR (*m*/*z* = 628). (**C**) ESI-MS spectra of NAD and *O*-Cr-ADPR.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.013](10.7554/eLife.02999.013)10.7554/eLife.02999.014Figure 4---figure supplement 3.Proposed mechanism of Sirt3 catalyzed nicotinamide adenine dinucleotide dependent decrotonylation.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.014](10.7554/eLife.02999.014)10.7554/eLife.02999.015Figure 4---figure supplement 4.ITC measurement for the binding affinity of Sirt3 toward crotonylated histone peptides.(**A**) Isothermal titration calorimetry measurement for the binding affinities of Sirt3 towards H3K4Cr, H3K9Cr, H3K27Cr, and H4K8Cr. (**B**) A summary of dissociation constants (Kd), enthalpy changes (ΔH), and entropy changes (ΔS) of Sirt3 for the crotonylated peptides.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.015](10.7554/eLife.02999.015)10.7554/eLife.02999.016Figure 4---figure supplement 5.Decrotonylation activity of sirtuins in vitro. The hydrolysis of the H3K4Cr peptide by sirtuins was analyzed by liquid chromatography--mass spectrometry.(**A**--**C**) Sirt1, Sirt2, and Sirt3 showed significant decrotonylation activities towards H3K4Cr. (**D, E**) Sirt5 and Sirt6 showed little decrotonylation activities towards H3K4Cr. Black traces show total ion intensity for all ion species with *m*/*z* from 300 to 2000 (i.e., total ion counts, TIC); pink traces show ion intensity (5× magnified) for masses of decrotonylated (unmodified) peptides; and blue traces show ion intensity (5× magnified) for masses of crotonylated peptides.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.016](10.7554/eLife.02999.016)10.7554/eLife.02999.017Figure 4---figure supplement 6.Michaelis--Menten plots showing the kinetics of Sirt3 and mutant Sirt3 (F180L) deacetylation on H3K4Ac.The enzyme concentrations and reaction times were used as indicated in 'Materials and methods'. For kinetic parameters, values are reported as mean ± s.e. (n=3).**DOI:** [http://dx.doi.org/10.7554/eLife.02999.017](10.7554/eLife.02999.017)

We next investigated whether other members of the sirtuin family could also function as decrotonylases. Consistent with the work of Denu and coworkers, Sirt1 and Sirt2 also catalyzed the hydrolysis of the H3K4Cr peptide, although they were relatively weaker binders towards this substrate ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In contrast, for Sirt5 or Sirt6, little hydrolysis of the crotonyl peptide was observed ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). These results agree well with the observation that the phenylalanine residue, which is involved in recognition of crotonyl lysine via π−π stacking interaction ([Figure 3C, D](#fig3){ref-type="fig"}), is only conserved in Sirt1--Sirt3 ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). To further examine the importance of this conserved phenylalanine to the decrotonylase activity of the enzyme, we mutated Phe180 of Sirt3 to a leucine residue (F180L), which lacks an aromatic ring as a π donor but retains a similar hydrophobicity. We then carried out kinetic studies on this F180L mutant Sirt3. The steady state kinetic data showed that the catalytic efficiency of Sirt3 F180L mutant (*k*~cat~/*K*~m~=21 s^−1^ M^−1^) for the hydrolysis of the H3K4Cr peptide was about 40-fold lower than that of wild-type Sirt3 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), indicating a critical role of the phenylalanine mediated π−π interaction in the decrotonylation activity of the enzyme. Interestingly, the F180L mutation caused only about a two-fold decrease in the deacetylation activity of the enzyme ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}). This result rules out the possibility that the observed significant decrease in the decrotonylase activity of the enzyme is caused by a potential disruption of the NAD binding pocket in the mutated Sirt3.

Sirt1, Sirt2, and Sirt3 remove Kcr marks from histone proteins in vitro {#s2-5}
-----------------------------------------------------------------------

To test whether Sirt1--Sirt3 decrotonylate proteins, we incubated whole-cell proteins that were resolved in a sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred onto a poly(vinylidene fluoride) (PVDF) membrane with the enzymes in the presence of NAD. A pan antibody against Kcr was used to assess protein crotonylation levels. While the incubations with Sirt1--Sirt3 had little influence on lysine crotonylation in most of the protein bands, substantial reductions in Kcr levels were observed in two bands with a molecular mass of approximately 15 kDa ([Figure 5A](#fig5){ref-type="fig"}). Considering Sirt1--Sirt3 can decrotonylate histone peptides in vitro, we speculated that these 15 kDa proteins with reduced Kcr levels could be histones. We therefore examined the decrotonylation activity of Sirt1--Sirt3 using purified core histone proteins as substrates. Indeed, Sirt1--Sirt3 not only reduced global Kcr levels of all core histones, they also showed robust decrotonylation activity towards two known histone Kcr sites, H3K4Cr and H3K27Cr ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).10.7554/eLife.02999.018Figure 5.Sirt3 regulates histone lysine crotonylation and gene expression.(**A**) Western blot analyses showing Sirt1--3 catalyzed decrotonylation of whole-cell lysates on the membrane. The arrows indicate the protein bands with reduction of crotonylation levels. Ponceau S staining was used as the loading control. (**B**) Western blot analyses showing the decrotonylation of purified histones catalyzed by Sirt1--3 in the reaction buffer. Ponceau S staining was used as the loading control. (**C**) Western blot analyses showing that Sirt3 knockdown caused the accumulations of H3K4Cr without effect on H3K4Ac, H3K4Me3, or H3K27Cr levels. (**D**) Western blot analyses showing that Sirt3 knockdown caused global histone crotonylation (as indicated by the arrows). H3 and actin were used as loading controls. (**E**) Chromatin immunoprecipitation--quantitative PCR analyses showing the changes in the histone Kcr levels of the indicated chromatin loci on Sirt3 knockdown. Quantitative PCR signal was normalized by a non-Sirt3 bound region of *Gapdh*. (**F**) Real time PCR analyses showing the changes in mRNA level of the indicated genes on Sirt3 knockdown. Quantitative PCR signal was normalized by *Gapdh*. Error bars indicated ± s.e. from four (**E**) or three (**F**) independent biological replicates. The p values are based on the Student\'s t test. \*p\<0.05, \*\*p \<0.01, \*\*\*p \<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.018](10.7554/eLife.02999.018)10.7554/eLife.02999.019Figure 5---figure supplement 1.Western blot analyses showing Sirt1-3 catalyzed decrotonylation of extracted histones on membrane.Ponceau S staining was used as the loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.019](10.7554/eLife.02999.019)10.7554/eLife.02999.020Figure 5---figure supplement 2.Analysis of the decrotonylation activities of Sirt1 and Sirt2 in cells.(**A**, **B**) Western blot analyses showing the influence of Sirt1 (**A**) or Sirt2 (**B**) knockdown on H3K4Cr and H3K27Cr levels in HeLa cells. (**C, D**) Western blot analyses showing that Sirt1 (**C**) or Sirt2 (**B**) knockdown did not cause an increase in global histone crotonylation levels (as indicated by the arrows). H3 and actin were used as loading controls.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.020](10.7554/eLife.02999.020)10.7554/eLife.02999.021Figure 5---figure supplement 3.Subcellular locolization of Sirt3.(**A**) Analysis of Sirt3 distribution in HeLa cells by fluorescence microscopy using anti-Sirt3 N-term antibody. Blue channel: DAPI. Red channel: Sirt3. (**B**) Western blot analyses showing the nuclear localization of endogenous Sirt3 using both anti-Sirt3 C-term and N-term antibodies. Western blot analyses of fibrillarin/histone H3 and HSP60 were used to show the purity of nuclear (NE) and mitochondrial extraction (Mito), respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.02999.021](10.7554/eLife.02999.021)

Sirt3 regulates histone Kcr levels in cells {#s2-6}
-------------------------------------------

We next examined whether Sirt1--Sirt3 regulate histone lysine crotonylation in cells. Although Sirt1 and Sirt2 can decrotonylate histone peptides and proteins in vitro, their knockdowns by siRNA did not cause an appreciable increase in crotonylation levels for both the global histone and the two tested Kcr (i.e., H3K4Cr and H3K27Cr) sites ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). In contrast, Sirt3 knockdown caused accumulation of global histone crotonylation and the H3K4Cr mark, while the histone H3K4Ac and H3K4Me3 levels were unaltered ([Figure 5C, D](#fig5){ref-type="fig"}), suggesting that Sirt3 selectively targets histone crotonylation. Interestingly, the crotonylation level on H3K27 was not influenced by the knockdown of Sirt3, which may be explained by the observation that Sirt3 showed weaker activity towards the H3K27Cr peptide in vitro ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). It should be noted that Sirt3 was found to localize predominantly to mitochondria and was mainly involved in metabolic regulations through controlling protein acetylation dynamics. However, recent evidence has suggested that Sirt3 can also be present in the nucleus in its full length form ([@bib29]; [@bib14]). Indeed, using an antibody that targets the N-terminal region of Sirt3, we detected endogenous full length Sirt3 in the nucleus of HeLa cells by both immunofluorescence and western blotting analyses ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Taken together, these data suggest that endogenous Sirt3 can function as an 'eraser' enzyme to regulate histone crotonylation dynamics in cells.

Sirt3 regulates histone Kcr levels and gene expression on its defined chromatin regions {#s2-7}
---------------------------------------------------------------------------------------

Finally, we sought to determine the potential biological consequence of histone decrotonylation mediated by Sirt3. It has been reported that Sirt3 can bind to chromatin and cause repression of the neighboring genes in U2OS cells ([@bib14]). We therefore hypothesized that Sirt3 could regulate gene transcription via controlling local histone Kcr levels. To test this hypothesis, we focused on seven candidate genes, *Baz2a*, *Brip1*, *Corin*, *Ptk2*, *Tshz3*, *Wapal*, and *Zfat*, whose transcription start sites are close to the Sirt3 enriched region. Chromatin precipitation (ChIP) coupled with quantitative PCR (qPCR) was performed in U2OS cells with the pan anti-Kcr antibody to measure Kcr levels near the transcription start sites of the candidate genes. As shown in [Figure 5E](#fig5){ref-type="fig"}, Sirt3 knockdown by siRNA resulted in significant increases in Kcr levels of five of the seven genes analyzed, indicating that Sirt3 may directly regulate crotonylation dynamics at the genomic loci where it binds. Interestingly, the mRNA levels of the three candidate genes with increased Kcr levels, *Ptk2*, *Tshz3*, and *Wapal*, were also significantly upregulated on Sirt3 knockdown ([Figure 5F](#fig5){ref-type="fig"}). Given that histone Kcr is enriched at active gene promoters and potential enhancers ([@bib33]), this positive correlation between the gene transcription level and the nearby histone Kcr level on Sirt3 knockdown suggests that Sirt3 might relieve a repressive effect on these target genes through 'erasing' histone Kcr 'marks'.

Discussion {#s3}
==========

We have established a robust chemical proteomics approach to comprehensively profile histone decrotonylases. There have been important advances in our ability to detect PTMs. However, we currently lack reliable methods to identify, without bias, enzymes that regulate the addition and removal of PTMs, as interactions between PTMs and their regulating enzymes can be weak and transient, thereby limiting the applicability of conventional biochemical 'pull-down' methods. Our CLASPI approach overcame this difficulty by applying photo-cross-linking chemistry to convert weak and transient enzyme--PTM interactions into irreversible covalent linkages, and enabled a systematic profiling of the 'erasers' of protein PTMs. The present study has also largely broadened the scope of CLASPI technology from finding PTM 'readers'([@bib21]; [@bib20]), which are usually involved in relatively more stable protein--protein interactions, to identifying dynamic and transient interactions between PTMs and their 'erasers'. We anticipate that this approach can be used to comprehensively profile 'erasers' of other PTMs, such as arginine demethylases.

Siruins were initially recognized as NAD-dependent deacetylases ([@bib13]; [@bib19]; [@bib28]). However, emerging evidence revealed that some sirtuins that displayed weak deacetylation activity had substrate specificity towards other acyl groups attached to lysine residues. For examples, Lin et al. recently demonstrated that Sirt5 can preferentially hydrolyze malonyl and succinyl lysine ([@bib5]; [@bib26]), and Sirt6 can remove long chain fatty acyl groups (e.g., myristoyl group) from lysine residues ([@bib16]). In this study, we demonstrated that the three human sirtuins, Sirt1--Sirt3, catalyzed the hydrolysis of crotonyl lysine. This newly discovered decrotonylase activity broadens the landscape of PTMs that are targeted by sirtuins, and it also provides new impetus to investigate the cellular mechanisms and functions of Sirt1--Sirt3, which to date have been considered solely as deacetylases. This finding is also partially in agreement with the work of Denu and coworkers, in which only Sirt1 and Sirt2 exhibited decrotonylase activity, whereas Sirt3 was totally inactive, towards a histone H3K9Cr peptide in their radioactive \[^32^P\]-NAD thin layer chromatography assay. In contrast, Sirt3 displayed robust decrotonylase activity against a variety of crotonylated histone peptides, including an H3K9Cr peptide in this study ([Figure 4](#fig4){ref-type="fig"}). Given the fact that the activity of Sirt3 can be peptide sequence-dependent ([Figure 4](#fig4){ref-type="fig"}), this discrepancy may be caused by the different H3K9Cr peptide substrates used in Denu\'s and this study, which consisted of amino acid residues 5--13 and 1--15 of histone H3, respectively.

We have demonstrated that endogenous Sirt3 functions as an 'eraser' to regulate histone crotonylation in cells. This finding opens new opportunities to investigate the cellular mechanisms and functions of histone crotonylation. In contrast, while the knockdowns of Sirt1 and Sirt2 did not cause accumulation of histone global or H3K4 crotonylation ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), we cannot rule out the possibility that these two sirtuins could target other histone crotonylation sites. Future studies are therefore needed to systematically profile mammalian crotonylome and analyze the lysine crotonylation sites that are targeted by Sirt1, Sirt2, and Sirt3, by comparing the corresponding wild-type and genetic knockout cells or tissues in conjunction with quantitative proteomics approaches.

The seven human sirtuins have distinct subcellular localizations. Sirt1, Sirt6, and Sirt7 are in the nucleus, Sirt3--Sirt5 localize to the mitochondria, and Sirt2 is primarily found in the cytoplasm ([@bib11]). However, Sirt3, in its full length form, has recently been found in the nucleus, and nuclear Sirt3 can associate with chromatin and result in repression of nearby genes ([@bib29]; [@bib14]). Based on the focused analysis at several Sirt3 target gene loci, the current study suggests a potential correlation of the transcriptional upregulation and the increase in local histone Kcr levels on Sirt3 knockdown. It also generates a hypothesis that Sirt3 could lead to silencing through 'erasing' Kcr at target genes. To test this hypothesis and examine the correlation between Sirt3 catalyzed histone deacrotonylation and gene expression genome-wide requires comprehensive profiling of global histone Kcr and gene expression regulated by Sirt3 using ChIP coupled to high throughput sequencing, in combination with RNA sequencing in future studies.

In addition, the same type of PTM at different modification sites of histones may have distinct effects on gene expression. For example, trimethylation at histone H3 Lys-4 (H3K4Me3) 'marks' genes that are being actively transcribed, whereas the same modification at H3 Lys-27 (H3K27Me3) 'marks' transcriptionally silent chromatin ([@bib24]). By analogy, it is possible that crotonylation at specific lysine sites of histones could also play different roles in the regulation of gene expression. This possibility may account for the fact that the transcription of the two genes (i.e., *Brip1* and *Zfat*) with elevated Kcr levels was not influenced in our study. The study of the effects of site-specific histone Kcr 'marks' (e.g., H3K4Cr) targeted by Sirt3 on the regulation of gene expression is an important next step.

Materials and methods {#s4}
=====================

Reagents {#s4-1}
--------

Unless otherwise noted, all chemical reagents were purchased from Sigma--Aldrich (St. Louis, MO). Dulbecco\'s Modified Eagle Medium (DMEM) was purchased from Life Technologies. Ethylene diamine tetraacetic acid (EDTA) free protease inhibitor was purchased from Roche Applied Science (Germany). Pre-stained protein ladder was purchased from Bio-Rad (Hercules, CA). Pre-cast polyacrylamide gels (4--12% NuPAGE Bis-Tris gels) were purchased from Life Technologies. Mass spectrometry grade trypsin was purchased from Promega (Madison, WI). High capacity streptavidin beads were purchased from ThermoFisher Scientific (Waltham, MA). Antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA) (anti-Sirt1, anti-Sirt2, and anti-γ-actin antibodies), Cell Signaling Technology (Danvers, MA) (anti-Sirt3, anti-HSP60, anti-fibrillarin, and anti-histone H3 antibodies), Abcam (United Kingdom) (anti-H3K4Ac and anti-H3K4Me3 antibodies), or PTM BioLabs (Chicago, IL) (anti-H3K4Cr, anti-H3K27Cr, and pan anti-crotonyllysine antibodies). Anti-Sirt3 N-term antibody was a generous gift from Dr Danny Reinberg (New York University, New York, United States).

Instrumentation {#s4-2}
---------------

In-gel fluorescence scanning was performed using a Typhoon 9410 variable mode imager (excitation 532 nm, emission 580 nm). Isothermal titration calorimetry measurements were performed on a MicroCal iTC200 titration calorimeter (Malvern Instruments, United Kingdom). Peptides were purified on a preparative HPLC system with Waters (Milford, MA) 2535 Quaternary Gradient Module, Waters 515 HPLC pump, Waters SFO System Fluidics Organizer, and Waters 2767 Sample Manager. Enzymatic reactions were monitored by an LC-MS system with Waters 1525 Binary HPLC Pump, Waters 2998 Photodiode Array Detector, and Waters 3100 Mass Detector. Detection of *O*-Cr-ADPR was carried out by Agilent (Santa Clara, CA) 1260 Infinity HPLC system connected to a Thermo Fisher Scientific LCQ DecaXP MS detector.

Peptide synthesis and purification {#s4-3}
----------------------------------

All peptides were synthesized on Rink-Amide MBHA resin following a standard Fmoc based solid phase peptide synthesis protocol. Removal of protecting groups and cleavage of peptides from the resin were done by incubating the resin with a cleavage cocktail containing 95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane, 1.5% water, and 1% thioanisole for 2 hr. Peptides were purified by preparative HPLC with an XBridge Prep OBD C18 column (30 mm×250 mm, 10 μm; Waters). Mobile phases used were water with 0.1% TFA (buffer A) and 90% acetonitrile (ACN) in water with 0.1% TFA (buffer B). Peptides containing photo-cross-linker (benzophenone) were eluted with gradient 15--40% buffer B in 40 min; all other peptides were eluted with gradient 5--35% buffer B in 40 min. The elution rate was 15 mL/min. The purity and identity of the peptides were verified by LC-MS.

Cell culture {#s4-4}
------------

HeLa S3, HEK293T, and HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were maintained in a humidified 37 °C incubator with 5% CO~2~.

Stable isotope labeling of amino acids in cell culture {#s4-5}
------------------------------------------------------

HeLa S3 cells were grown in suspension at 37°C in a humidified atmosphere with 5% CO~2~ in DMEM medium (--Arg, --Lys; Life Technologies) containing 10% dialyzed fetal bovine serum (Life Technologies), penicillin--streptomycin, and supplemented with 22 mg/L ^13^C~6~^15^N~4~-L-arginine (Cambridge Isotope Laboratories, Tewksbury, MA) and 50 mg/L ^13^C~6~^15^N~2~-L-lysine (Cambridge Isotope) or the corresponding non-labeled amino acids (Peptide International, Louisville, KY). Harvested cell pellets were washed with ice cold phosphate buffered saline (PBS) and frozen in liquid N~2~. The cell powder grinded with a Ball Mill (Retch MM301) was stored at −80 °C until use.

Preparation of whole-cell lysates for CLASPI experiment {#s4-6}
-------------------------------------------------------

To prepare whole-cell lysates, the frozen cell powder was first resuspended in a hypotonic buffer (10 mM HEPES, pH 7.5, 2 mM MgCl~2~, 0.1% Tween-20, 20% glycerol, 2 mM phenylmethylsulfonyl fluoride (PMSF), and Roche Complete EDTA free protease inhibitors) and incubated for 10 min at 4 °C. The suspension was centrifuged at 16,000×g for 15 min at 4 °C and the supernatant was kept for use later. The pellet was resuspended in a high salt buffer (50 mM HEPES, pH 7.5, 420 mM NaCl, 2 mM MgCl~2~, 0.1% Tween-20, 20% glycerol, 2 mM PMSF, and Roche Complete EDTA free protease inhibitors) and incubated for 30 min at 4 °C. The suspension was centrifuged at 16,000×g for 15 min at 4 °C, and the supernatant was combined with the soluble fraction in hypotonic buffer to give the whole-cell lysates.

CLASPI photo-cross-linking {#s4-7}
--------------------------

In a 'selectivity filter' experiment, probe **1** and probe **C** were incubated with heavy and light SILAC whole-cell lysates, respectively, in the binding buffer (50 mM HEPES, pH 7.5, 168 mM NaCl, 2 mM MgCl~2~, 0.1% Tween-20, 20% glycerol, 2 mM PMSF, and Roche Complete EDTA free protease inhibitor cocktail) for 15 min at 4 °C. The samples were then irradiated at 365 nm using a Spectroline ML-3500S UV lamp for 15 min on ice. In 'an affinity filter experiment', the heavy and light SILAC lysates were reacted with probe **1** in the absence and presence, respectively, of H3K4Cr (1--15) peptide (30 μM) as a competitor. After photo-cross-linking, the heavy and light lysates were pooled.

Cu(I)-catalyzed cycloaddition/click chemistry {#s4-8}
---------------------------------------------

Briefly, to the prepared samples, 100 μM of rhodamine azide for in-gel fluorescence scanning or cleavable biotin-azide for streptavidin enrichment were added, followed by 1 mM tris(2-carboxyethyl)phosphine and 100 μM tris\[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl\]amine, and the reactions were initiated by the addition of 1 mM CuSO~4~. The reactions were incubated for 1.5 hr at room temperature.

Streptavidin affinity enrichment of biotinylated proteins {#s4-9}
---------------------------------------------------------

After the click chemistry with cleavable biotin-azide, the reaction was quenched by adding 4 volumes of ice cold acetone to precipitate the proteins. After washing with ice cold methanol twice, the air dried protein pellet was dissolved in PBS with 4% SDS, 20 mM EDTA, and 10% glycerol by vortexting and heating. The solution was then diluted with PBS to give a final concentration of SDS of 0.5%. High capacity streptavidin agarose beads (Thermo Fisher Scientific) were added to bind the biotinylated proteins with rotating for 1.5 hr at room temperature. To remove non-specific binding, the beads were washed with PBS with 0.2% SDS, 6 M urea in PBS with 0.1% SDS, and 250 mM NH~4~HCO~3~ with 0.05% SDS. The enriched proteins were then eluted by incubating with 25 mM Na~2~S~2~O~4~, 250 mM NH~4~HCO~3~, and 0.05% SDS for 1 hr. The eluted proteins were dried down with SpeedVac.

Sample preparation for mass spectrometry {#s4-10}
----------------------------------------

The dried proteins were resuspended in 30 μL of lithium dodecyl sulfate sample loading buffer (Life Technologies) with 50 mM dithiothreitol (DTT), heated at 75 °C for 8 min, and then reacted with iodoacetamide in the dark for 30 min to alkylate all of the reduced cysteines. Proteins were then separated on a Bis-Tris gel, followed by fixation in a 50% methanol/7% acetic acid solution. The gel was stained by GelCode Blue stain (Pierce). The diced 1 mm ([@bib8]) cubes of gels were then destained by incubating with 50 mM ammonium bicarbonate/50% acetonitrile for 1 hr. The destained gel cubes were dehydrated in acetonitrile for 10 min and rehydrated in 25 mM NH~4~HCO~3~ with trypsin for protein digestion at 37 °C overnight. The resulting peptides were enriched with StageTips. The peptides eluted from the StageTips were dried down by SpeedVac and then resuspended in 0.5% acetic acid for analysis by LC-MS/MS.

Mass spectrometry {#s4-11}
-----------------

Mass spectrometry was performed on an LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher Scientific). First, peptide samples in 0.1% formic acid were pressure loaded onto a self-packed PicoTip column (New Objective, Woburn, MA) (360 μm od, 75 μm id, 15 μm tip), packed with 7--10 cm of reverse phase C18 material (ODS-A C18 5-μm beads from YMC America, Allentown, PA), rinsed for 5 min with 0.1% formic acid, and subsequently eluted with a linear gradient from 2% to 35% B for 150 min (A=0.1% formic acid, B=0.1% formic acid in ACN, flow rate ∼200 nL/min) into the mass spectrometer. The instrument was operated in a data-dependent mode, cycling through a full scan (300--2000 *m*/*z*, single μscan) followed by 10 CID MS/MS scans on the 10 most abundant ions from the immediate preceding full scan. Cations were isolated with a 2 Da mass window and set on a dynamic exclusion list for 60 s after they were first selected for MS/MS. The raw data were processed and analyzed using MaxQuant (version 1.2.2.5). A human fasta file (ipi.HUMAN.v.3.68.fasta) was used as the protein sequence searching database. Default parameters were adapted for protein identification and quantification. In particular, parent peak MS tolerance was 6 ppm, MS/MS tolerance was 0.5 Da, minimum peptide length was 6 amino acids, and maximum number of missed cleavages was 2. The proteins quantified were supported by at least two quantification events. Both the 'selectivity filter' and 'affinity filter' experiments were repeated twice, and only the proteins that were identified and quantified in all experiments were reported.

In-gel fluorescence visualization {#s4-12}
---------------------------------

The click chemistry reactions were quenched by adding 1 volume of 2×sample buffer. The proteins were heated at 85 °C for 8 min, and resolved by SDS-PAGE. The labeled proteins were visualized by scanning the gel on a Typhoon 9410 variable mode imager (excitation 532 nm, emission 580 nm).

Expression and purification of recombinant human sirtuins {#s4-13}
---------------------------------------------------------

Plasmids of Sirt1 (193--747), Sirt2 (36--356), Sirt5 (34--302), and Sirt6 (1--314) for Escherichia *coli* expression were generated as previously described ([@bib7]; [@bib5]; [@bib12]; [@bib16]). Plasmids of Sirt3 (102--399) cloned in pTrcHis 2C vector for *E. coli* expression and full length Sirt3 (wide-type and mutant H248Y) cloned into pcDNA3.1 vector for mammalian cell expression were generous gifts from Dr Eric Verdin (University of California, San Francisco). Sirt3 mutant F180L was generated by site directed mutagenesis. All of the proteins were expressed in *E. coli* Rosetta cells. To induce expression of target proteins, isopropyl β-D-1-thiogalactopyranoside was added to a final concentration of 0.2 mM when OD~600~ reached 0.6, and the culture was grown at 15 °C (Sirt3 at 25 °C) for 16--18 hr. Cells were harvested and resuspended in lysis buffer A (50 mM Tris--HCl, pH 7.5, 500 mM NaCl, 1 mM PMSF, and Roche EDTA free protease inhibitors, for Sirt1, Sirt2, and Sirt6) or buffer B (50 mM Tris--HCl, pH 7.5, 150 mM NaCl, 1 mM PMSF, and Roche EDTA free protease inhibitors, for Sirt3 and Sirt5). Following sonication and centrifugation, the supernatant was loaded onto a nickel column pre-equilibrated with lysis buffer. The column was washed with 5 column volumes of wash buffer (lysis buffer with 30 mM imidazole) and then the target proteins were eluted with elution buffer (lysis buffer with 250 mM imidazole). After purification, Sirt2 was digested by UPL1 at 4 °C overnight and purified by a Highload 26/60 Superdex75 gel filtration column (GE Healthcare Life Sciences, United Kingdom). Sirt6 was purified by SP column and Superdex75 gel filtration column. Others were loaded onto a Superdex75 gel filtration or Highload 26/60 Superdex200 (for Sirt1) column. After concentration, the target proteins were frozen and stored at −80 °C.

Isothermal titration calorimetry measurements {#s4-14}
---------------------------------------------

Experiments were performed at 25 °C on a MicroCal iTC200 titration calorimeter (Malvern Instruments). The reaction cell containing 200 μL of 100--200 μM proteins was titrated with 17 injections (firstly 0.5 μL, and all subsequent injections 2 μL of 1.5--2.5 mM peptides). The binding isotherm was fit with Origin 7.0 software package (OriginLab, Northampton, MA) that uses a single set of independent sites to determine the thermodynamic binding constants and stoichiometry.

Crystallization, X-ray data collection, and structure determination {#s4-15}
-------------------------------------------------------------------

Sirt3/H3K4Cr mixtures were prepared at a 1:20 protein/peptide molar ratio and incubated for 60 min on ice. Crystals of Sirt3 (102--399) complexed with H3K4Cr (1--10) peptide were obtained by the hanging drop vapor diffusion method at 291 K using commercial screens from Hampton Research (Aliso Viejo, CA). Each drop, consisting of 1 μL of 10 mg/mL protein complex solution (20 mM Tris--HCl, pH 7.4, 100 mM NaCl, and 5 mM DTT) and 1 μL of reservoir solution, was equilibrated against 400 μL of reservoir solution. The qualified crystals of Sirt3 grew with a cube profile within 1 week with a reservoir containing 12% PEG4K, 0.1 M sodium malonate, pH 6.5, and 5% isopropanol. The mixture of 25% glycerol with the reservoir solution above was used as the cryogenic liquor. The X-ray diffraction data were collected at 100 K in a liquid nitrogen gas stream using the Shanghai Synchrotron Radiation Facility beamline 17U (λ = 0.9791 Å). A total of 120 frames were collected with a 1° oscillation and the data were indexed and integrated using the program HKL2000 ([@bib25]). The complex structure of Sirt3 with H3K4Cr peptide was solved by molecular replacement using the program Molrep from the CCP4 Suit ([@bib37]), with the published Sirt3 structure (PDB: 3GLR) ([@bib17]) as the search model. Refinement and model building were performed with REFMAC5 and COOT from CCP4. The X-ray diffraction data collection and structure refinement statistics are shown in [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}.

Enzymatic reactions {#s4-16}
-------------------

The enzymatic activities of human sirtuins were measured by detecting the removal of the crotonyl group from peptides ([@bib5]). Sirtuin protein (5 μM) was incubated with 500 μM of corresponding crotonylated peptides and 1 mM of NAD in a reaction buffer containing 20 mM Tris--HCl buffer (pH 7.5) and 1 mM DTT at 37 °C for 2 hr. The reactions were stopped by adding one-third reaction volume of 20% TFA and immediately frozen in liquid N~2~. For Sirt3, samples without NAD or without enzyme were treated under the same conditions as the controls. Samples were then analyzed by LC-MS with a Vydac 218TP C18 column (4.6 mm×250 mm, 5 μm; Grace Davison, Columbia, MD). Mobile phases used were 0.05% TFA in water (buffer A) and 0.05% TFA in ACN (buffer B). The flow rate for LC was 0.6 mL/min. The peptide mixtures were eluted by buffer A for 10 min and then 0--30% buffer B over 10 min. MS started to record at 10 min for each injection.

Determination of *k*~cat~ and *K*~m~ {#s4-17}
------------------------------------

Enzyme was incubated with different concentrations of corresponding peptides bearing two tryptophans at the C terminus (20, 40, 60, 80, 100, 200, and 500 μM) and 1.0 mM NAD in 20 mM Tris--HCl buffer (pH 7.5) containing 1 mM DTT in 25 μL reaction at 37°C for a certain period of time within the initial linear range. The enzyme concentration and reaction time used were: Sirt3--H3K4Ac: 1 μM enzyme, 5 min; Sirt3--H3K4Cr: 1 μM enzyme, 20 min; Sirt3 (F180L)--H3K4Ac: 0.8 μM enzyme, 5 min; and Sirt3 (F180L)--H3K4Cr: 5 μM enzyme, 20 min. The reactions were stopped by adding one-third reaction volume of 20% TFA and immediately frozen in liquid N~2~. Samples were then analyzed by HPLC with a Vydac 218TP C18 column (4.6 mm×250 mm, 5 μm; Grace Davison). Mobile phases used were water with 0.1% TFA (buffer A) and 90% ACN in water with 0.1% TFA (buffer B). The wavelength for UV detection was 280 nm. The analysis gradient for deacetylation samples was 16% buffer B for 20 min with a flow rate at 1.5 mL/min. The analysis gradient for decrotonylation samples was 15--35% buffer B in 12 min with a flow rate at 1.0 mL/min.

Detection of *O*-Cr-ADPR {#s4-18}
------------------------

Sirt3 (5 μM) was incubated with 500 μM of H3K4Cr (1--15) peptide and 1 mM of NAD in a reaction buffer containing 20 mM Tris--HCl buffer (pH 7.5) and 1 mM DTT at 37°C for 2 hr. The reactions were stopped by immediately freezing in liquid N~2~. Sample was then analyzed by LC-MS with a VisionHT C18 column (2.1 mm×150 mm, 3 μm; Grace Davison) on an Agilent 1260 Infinity HPLC system, followed by Thermo Fisher Scientific LCQ DecaXP MS Detector. Mobile phases used were 0.02% TFA in water (buffer A) and 90% ACN in water with 0.02% TFA (buffer B). The flow rate for LC was 0.2 mL/min. The sample was eluted by buffer A for 10 min and then 0--10% buffer B over 10 min. The wavelength for UV detection was 260 nm. MS started to record at 10 min.

RNAi experiments {#s4-19}
----------------

Sirt1 siRNA 15 nM (Santa Cruz Biotechnologies), Sirt2 siRNA 30 nM (Thermo Fisher Scientific), or Sirt3 siRNA 30 nM (Thermo Fisher Scientific) was transfected into a HeLa cell line with DharmaFECT 1 Transfection Reagent (Thermo Fisher Scientific), according to the manufacturer\'s instructions. Corresponding concentrations of control siRNA were used as negative controls. Following transfection, cells were then maintained in a humidified 37 °C incubator with 5% CO~2~ for another 48 hr (for Sirt1 and Sirt2) or 72 hr (for Sirt3).

Histone extraction {#s4-20}
------------------

An acid extraction method was used to isolate histones from HeLa S3 cells ([@bib31]). Briefly, the harvested HeLa S3 cell pellet was resuspended with lysis buffer (10 mM Tris--HCl pH 8.0, 1 mM KCl, 1.5 mM MgCl~2~, 1 mM DTT 2 mM PMSF, and Roche Complete EDTA free protease inhibitors) and incubated at 4 °C by rotating for 1 hr. The intact nuclei were pelleted by centrifuging at 10,000×g for 10 min at 4 °C. To extract histones, 0.4 N H~2~SO~4~ was added to resuspend the nuclei, followed by rotating at 4°C overnight. After centrifuging to remove the nuclei debris, histones were precipitated by adding 100% trichloroacetic acid drop by drop (trichloroacetic acid final concentration 33%). The precipitated histones were pelleted at 16,000×g for 10 min at 4 °C and washed with ice cold acetone twice. The air dried protein pellet was dissolved with ddH~2~O and stored at −80 °C for later use.

On-membrane decrotonylation experiment {#s4-21}
--------------------------------------

HeLa S3 whole-cell lysate (20 μg) or 5 μg of extracted histones were resolved by SDS-PAGE gel and transferred to PVDF membranes. The membranes were incubated with or without 0.1 μM of Sirt3 in reaction buffer (25 mM Tris--HCl, 130 mM NaCl, 3 mM KCl, 1 mM MgCl~2~, and 1 mM DTT, pH 7.5) containing 1 mM NAD at 37 °C for 2 hr.

In-solution decrotonylation experiment {#s4-22}
--------------------------------------

Extracted histones (4 μg) were incubated with or without 1 μM or 5 μM of Sirt3 in reaction buffer (25 mM Tris--HCl, 130 mM NaCl, 3 mM KCl, 1 mM MgCl~2~, and 1 mM DTT, pH 7.5) containing 1 mM NAD at 37 °C overnight.

Immunofluorescence {#s4-23}
------------------

HeLa cells grown on coverslips were fixed with 3.7% polyformaldehyde in PBS, permeabilized with 0.1% Triton X-100 in PBS, and blocked for 30 min at room temperature using 5% bovine serum albumin (dissolved with PBS containing 0.1% Triton X-100). Cells were incubated with primary antibody overnight at 4°C and washed trice with PBST (0.1% Tween-20 in PBS) prior to secondary antibody (containing DAPI for nucleus staining) incubation at room temperature for 1 hr. Washed cells were then subjected to a Zeiss LSM 510 laser scanning confocal microscope.

Subcellular fractionation {#s4-24}
-------------------------

In brief, HeLa cells were harvested by centrifugation and washed with PBS twice; all subsequent steps were performed at 4 °C. Cells were then suspended in 5 cell pellet volumes of buffer A (10 mM HEPES, pH 7.9 at 4 °C, 1.5 mM MgCl~2~, 10 mM KCl, and 0.5 mM DTT) followed by incubation for 10 min. After centrifugation, cells were resuspended in 2 cell pellet volumes of buffer A and lysed by Dounce homogenizer (B type pestle) with homogenate checked by microscopy. The cell lysis was layered over 30% sucrose in buffer A and then centrifuged for 15 min at 800×g. The resulting pellet was recovered from the sucrose phase, washed by buffer A twice, and then extracted by buffer C (20 mM HEPES, pH 7.9, 25% (vol/vol) glycerol, 0.42 M NaCl, 1.5 mM MgCl~2~, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM DTT) for 30 min at 4 °C. After centrifugation at 12,000×g for 30 min, the supernatant was termed the nuclear fraction. The resulting supernatant was centrifuged twice at 800×g to complete the pellet nuclei and intact cell. The supernatant was then centrifuged at 7,000×g to pellet the mitochondria followed by washing twice with buffer A. The mitochondria were then lysed by TXIP-1 buffer (1% Triton X-100 (vol/vol), 150 mM NaCl, 0.5 mM EDTA, and 50 mM Tris--HCl, pH 7.4). Protein concentration was determined by BCA assay.

Immunoblotting {#s4-25}
--------------

Proteins separated by SDS-PAGE were transferred onto a PVDF membrane which was then blocked (5% non-fat dried milk and 0.1% Tween-20 in PBS) for 1 hr at room temperature. The membrane was incubated with primary antibody diluted in PBST with 2% bovine serum albumin, followed by washing with PBST for 5 min trice, incubated with goat anti-rabbit-horseradish peroxidase conjugated secondary antibody (1:20000; Santa Cruz Biotechnologies), or rabbit anti-mouse- horseradish peroxidase conjugated secondary antibody (1:5000; Santa Cruz Biotechnologies) diluted in PBST for 1 hr at room temperature, and then visualized with western blotting detection reagents (Thermo Fisher Scientific).

Gene expression analysis {#s4-26}
------------------------

Total RNA was isolated using TRIzol Reagent (Life Technologies). RNA was reverse transcribed into cDNA by M-MLV Reverse Transcriptase (Life Technologies) using oligo (dT) primers. qPCR was performed using Power SYBR Green PCR Master Mix (Life Technologies) on an ABI StepOnePlus system following the manual's instructions. All primers used are listed in [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}.

ChIP and qPCR {#s4-27}
-------------

Cells were cross linked by 1% formaldehyde for 10 min and quenched by 0.125 M glycine for 5 min at room temperature. Cells were then lysed by ChIP lysis buffer (5 mM PIPES pH 8.0, 85 mM KCl, and 1% IGEPAL CA-630) and homogenized using a glass Dounce homogenizer (type B pestle). The nuclear fraction was precipitated and lysed in nuclei lysis buffer (50 mM Tris--HCl, pH 8.0, 10 mM EDTA, and 1% SDS) for 30 min at 4 °C. The nuclear lysis was sonicated to a chromatin ranging from 600 bp to 800 bp. Immunoprecipitation was done in immunoprecipitation dilution buffer (50 mM Tris--HCl, pH 7.4, 150 mM NaCl, 1% IGEPAL CA-630, 0.25% deoxycholic acid, and 1 mM EDTA) using Dynabeads coupled with Protein G (Life Technologies). Chromatin (5 μg) and 8 μg of pan anti-crotonyllysine antibody were used for each ChIP reaction. Chromatin complex was eluted from beads by ChIP elution buffer (50 mM NaHCO~3~ and 1% SDS) and added to 5 M NaCl to a final concentration of 0.54 M. To reverse cross links of protein/DNA complex to free DNA, samples were incubated at 65 °C for 2 hr followed by 95 °C for 15 min. After incubation with RNase (Thermo Fisher Scientific) for 20 min at 37 °C, DNA was recovered and used for qPCR, as described above. All primers used are listed in [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}.
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Major dataset
-------------

The following previously published dataset was used:

Jin L, Wei W, Jiang Y, Peng H, Cai J, Mao C, Dai H, Choy W, Bemis JE, Jirousek MR, Milne JC, Westphal CH, Perni RB, 2009,Crystal structure of human SIRT3 with acetyl-lysine AceCS2 peptide,<http://www.pdb.org/pdb/explore/explore.do?structureId=3GLR>,Publicly available at RCSB Protein Data Bank.
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Decision letter

van der Donk

Wilfred

Reviewing editor

University of Illinois-Urbana Champaign

,

United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Identification of \'erasers\' for lysine-crotonylated histone marks using a chemical proteomics approach" for consideration at *eLife*. Your article has been evaluated by Michael Marletta (Senior editor), Wilfred van der Donk (Reviewing editor), and 3 reviewers. The study was judged to be of interest and could be suitable for *eLife* provided you are able to fully address some critical questions that were raised.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the comments below to help you prepare a revised submission. Overall, the reviewers found the observed decrotonylation activity interesting and of high potential impact, but they felt that some key and essential experiments are required to support the interpretation of the authors.

1\) One of the main concerns is the localization of Sirt3. The authors cite references that suggest it could be in the nucleus, but other studies have reported exclusive localization to the mitochondria. Without conclusive evidence that active Sirt3 is indeed in the nucleus in the experiments performed, the relevance of histone decrotonylation would be in question.

2\) A closely related question is the impact of Sirt1-3 knockdown/overexpression on histone acetylation and methylation (1, 2 and 3 Me) levels of H3K4. For instance, could the observed effects on crotonylation be caused by changes of other modifications at these sites in these proteins due to knockdown? These experiments would be straightforward and are critical to support the interpretation of the authors.

3\) A different important concern is the lack of quantitation with respect to the decrotonylation activity. The authors convincingly demonstrate that decrotonylation occurs *in vitro* and that O-crotonyl-ADPR is formed, but without any steady-state kinetic parameters it is unclear how robust (and hence meaningful) this activity is. Only physiologically relevant kinetic parameters would support a functional role of histone decrotonylation.

4\) The biological consequences (and therefore importance) of decrotonylation activity are currently not clear. Given the apparent selectivity for histones (based on [Figure 5a](#fig5){ref-type="fig"}), a relatively straightforward first look would involve analysis of transcriptional changes upon knockdown of Sirt3. RNA-seq with H3K4Cr Chip-Seq, or alternatively focusing on a few loci and examining potential correlations of H3K4Cr (Chip-PCR) upon Sirt3 knockdown, would provide important information.

5\) The structural studies of crotonylated peptide to SIRT3 propose a binding mode involving Phe180 that is highly conserved. What is not mentioned is that this residue is known to interact strongly with NAD in prior structural work (e.g. Wolbergers comprehensive studies, which include termolecular structures of both NAD and peptides bound to sirtuin active sites). The authors state that this residue is not conserved in SIRT4-7, but its identification and conservation has been supported by many sequence comparison and structural studies. The observed lack of decrotonylation activity upon mutation may therefore be a consequence of disrupted NAD binding rather than demonstrating substrate selectivity. It also questions whether the observed binding mode in the absence of NAD is relevant if NAD is bound to the enzyme. Steady state parameters for the decrotonylation activity of the mutant and binding studies of NAD and the crotonylated peptide to the mutant may be able to address these concerns.

10.7554/eLife.02999.025

Author response

*1) One of the main concerns is the localization of Sirt3. The authors cite references that suggest it could be in the nucleus, but other studies have reported exclusive localization to the mitochondria. Without conclusive evidence that active Sirt3 is indeed in the nucleus in the experiments performed, the relevance of histone decrotonylation would be in question*.

We appreciate this concern raised by the reviewers and also agree that the subcellular localization of Sirt3 has been debated. To address this issue, we would like to provide both a detailed literature review and our own experimental data below.

*Literature review*:

We first carefully reviewed the literature for the detailed experimental data that indicate the mitochondrial and nuclear localization of Sirt3, respectively. Here we summarize our findings in the table shown below.

**Table:** Summary of studies of Sirt3's subcellular localization in the literature.Ref. No.Sirt3 LocalizationEvidenceFig. No. in Ref.Cell TypeAntibodyMethodsIBIFGFPOthers**1**MitochondriaOverexpressed Sirt3-FLAG was found in mitochondrial extraction.**2b**HEK293Tanti-FLAG✔MitochondriaEndogenous Sirt3 was detected in mitochondrial fraction with rabbit sirt3 antiserum (anti-sirt3 C term 15 AAs).**2c**HEK293Tanti-Sirt3 C-term✔MitochondriaOverexpressed Sirt3-GFP localized in mitochondria**2a**HeLa✔**2**MitochondriaOverexpressed Sirt3-EGFP was detected in mitochondria by immunoelectron microscopy.**6**Cervical carcinomaImmunoelectronMitochondriaOverexpressed full length Sirt3-EGFP was present in mitochondria**3, 4, 5**COS7✔**3**MitochondriaOverexpressed Sirt3-GFP was detected in mitochondria.**1a**NHF✔MitochondriaThere was no detectable signal of overexpressed Sirt3 with N-term-HA tag by immunofluorescence.**−**NHFanti-HA,✔MitochondriaOverexpressed of Sirt3-V5-His with C-term-tag was detected in mitochondria by immunofluorescence.**3a, b**NHF HeLaanti-V5✔MitochondriaSirt3-V5-His was detected in mitochondrial extraction using anti-V5 antibody.**3c**HEK293Tanti-V5✔**4**MitochondriaOverexpressed mSirt3-FLAG was detected in mitochondria by immunofluorescence.**2a**NIH3T3 (mouse)anti-FLAG✔**5**MitochondriaCo-expression of AceCS1/2 with Sirt3-FLAG down-regulated acetylation level on AceCS2 (in mitochondria), but not AceCS1 (in nucleus).**1e, 3c**COS7anti-FLAG✔**6**MitochondriaEndogenous Sirt3 was detected in mitochondrial extraction using anti-sirt3 C-term serum.**1b-d**HEK293anti-sirt3 C-term✔MitochondriaAceCS2-FLAG localized in mitochondria. Endogenous Sirt3 was co-precipitated from cell stably expressing AceCS2-FLAG using anti-FLAG antibody.**1a, 3e**HeLa HEK293anti-FLAG anti-sirt3 C-term✔MitochondriaOverexpression of Sirt3-FLAG down-regulated acetylation level on AceCS2.**3d**COS-1✔**7**MitochondriaOverexpressed Sirt3-myc was detected in mitochondria by immunofluorescence.**1a**COS7anti-Myc tag✔MitochondriaOverexpressed Sir3-Myc was detected in mitochondrial extraction using anti-Myc antibody.**1b**COS7anti-Myc tag✔**Nucleus**Co-expression of Sirt5-FLAG with Sirt3-Myc promoted translocation of Sirt3 into nucleus.**2a**COS7anti-Myc tag✔**Nucleus**Overexpressed Sirt3-Myc could be detected in total lysate but not in post-nuclear supernatant after co-expression with Sirt5-FLAG.**2b, c**COS7anti-Myc tag✔MTSSirt3-Myc with mitochondria targeting signal (72-75) mutant to 4 Ala was found in in both nucleus and cytoplasm.**3**COS7anti-Myc tag✔NTSSirt3-Myc with nuclear targeting signal (214-216) mutant to 3 Ala was detected in nucleus and cytoplasm when co-expressed with Sirt5.**4b, c**COS7anti-Myc tag✔**8**MitochondriaEndogenous Sirt3 was detected in mitochondria isolation using anti-Sirt3 C-term antibody.**1b-d**mouseanti-Sirt3 C-term✔**9**MitochondriaOverexpressed Sirt3-FLAG or Sirt3-Myc was detected in mitochondria by immunofluorescence.**1A**HeLa HEK293T U2OSanti-FLAG, anti-Myc✔MitochondriaLMB treatment did not result in nuclear translocation of Sirt3-FLAG but did for HDAC7.**1B, C**HeLa U2OSanti-FLAG, anti-Myc✔MitochondriaOverexpressed POLG2-HA, a positive control for mitochondrial localized proteins, was detected in mitochondria isolation, by not for Sirt3-FLAG.**2A**HEK293anti -Sirt3 SC49744✔**10Nucleus**Full length Sirt3 was detected in all subcellular fractionation parts.**5**Cardiomyocytesanti-sirt3 Ab56214,✔**Nucleus**Endogenous Sirt3 was detected in nucleus by microscopy.**6a-e**Cardiomyocytesanti-sirt3 SC49744✔**Nucleus**Overexpressed Sirt3 was detected in nucleus by immunofluorescence.**6f** **7a, b**Cardiomyocytesanti -Sirt3 SC49744✔**Nucleus**Full length Sirt3 was detected in nuclear extraction using anti-Sirt3 antibody.**7d, g**Cardiomyocytesanti-sirt3 SC49744✔**Nucleus**Ku70, a nuclear protein, could be co-precipitated by anti-Sirt3 antibody.**8a**Cardiomyocytesanti-Sirt3 AP6242a✔**Nucleus**Ku70 was co-precipitated with FLAG antibody from Sirt3-FLAG expressing cells but not from cells expressing the FLAG tag alone.**8b**COS7anti-FLAG,✔**Nucleus**Sirt3 was pulled down with Ku70 using anti-Ku70 antibody.**8c**Cardiomyocytesanti-sirt3 PAB11098✔**Nucleus**Precipitation of recombinant Ku70 by recombinant Sirt3 verified their direct interaction *in vitro.***8d**✔**Nucleus**Acetylation level on Ku70 was reduced by overexpressed Sirt3 and enhanced by Sirt3 knockdown via RNAi.**9d10c, d**HeLa✔**Nucleus**Sirt3 was capable of deacetylation on Ku70 to enhance Ku70/Bax bindig to prevent cell death.**11, 12**HeLa✔**11Nucleus**Endogenous full-length Sirt3 was detected in nucleus by immunofluorescence using anti-Sirt3 N-term antibody.**1b**HeLa & HEK293Tanti-sirt3 N-term✔**Nucleus**Co-transfection of Gal4-Sirt3 and luciferase reporter plasmid showed the nucleus localization of Gal4-Sirt3.**3b**HEK293Tanti-Gal-DBD✔**Nucleus**Full length Sirt3 resided in the nucleus and expelled from nucleus upon cellular stress.**5**HeLa S3anti-sirt3 N-term✔**Nucleus**The synthesis of tetracycline-inducible Sirt3 harboring a C-term HA-tag is processed in the nucleus.**6a**HEK293Tanti-HA✔**Nucleus**Overexpressed Sirt3-HA was detected in nuclear extraction.**6b**HEK293Tanti-HA✔**12Nucleus**Stress-induced the degradation of full-length Sirt3 in nuclei.**5b, c**HeLa, U2OS, HEK293Tanti-HA anti-Sirt3 sc-49744✔**Nucleus**SIRT3 localizes to defined chromatin regions and regulates gene expression.**6, 7, 8**U2OS✔**Nucleus**Interaction of endogenous Sirt3 and SKP2, a protein found outside mitochondria, was validated by immunoprecipitation.**4**HEK293Tanti-HA anti-FLAG anti-Sirt3 C73E3✔
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From the analysis shown in this table, we found mainly two lines of evidences that suggest Sirt3 localizes exclusively in mitochondria. The first line of evidence involves the direct visualization of recombinant GFP-fused or epitope-tagged Sirt3 in the mitochondria of cells through GFP fluorescence or immunofluorescence (IF) using antibodies against the fused tags, respectively (see references 1-4 and 7-9 in the table above). The second line of evidence is from the detection of overexpressed epitope-tagged Sirt3 and endogenous Sirt3 in the mitochondrial fractions of cells by immunoblotting (IB) using anti-tag and anti-Sirt3 antibodies, respectively (see reference 1,3 and 6-9 in the table above). It should be noted that in these studies the detection of endogenous Sirt3 relied on antibodies that recognize the C-terminal regions of Sirt3. These anti-Sirt3 (*C*-term) antibodies have been used to reveal the localization of endogenous Sirt3, more specifically, short-form (i.e., N-terminal truncated) Sirt3, in the mitochondria fractions using immunoblotting analysis. However, the application of the anti-Sirt3 (*C*-term) antibodies to detect of endogenous full-length Sirt3 has not been limited in these studies, most likely due to the relatively low abundance of full-length Sirt3. Also, the IF detection of endogenous Sirt3 using these antibodies has NOT been shown in these studies.

In contrast, as shown in the table, several studies have provided evidences to support that while short-form Sirt3 predominantly localize in the mitochondria, full-length Sirt3 can be present in the nucleus.(need to check carefully about IB data) Reinberg *et al.* generated an antibody that specifically targets a Sirt3 N-terminal region. Using this anti-Sirt3 (*N*-term) antibody, endogenous Sirt3 was detected in the nucleus of HEK 293 and HeLa cells by IF (see reference 11 in the table above). Furthermore, a ChIP-Seq experiment using the anti-Sirt3 (*N*-term) antibody revealed the Sirt3's localization on chromatin and the transcriptional level of several tested genes where Sirt3 localizes were indeed regulated by Sirt3 (see reference 12 in the table above).

Our experimental results:

To examine the subcellular localization of Sirt3, we also performed a couple of experiments by ourselves. First, we prepared mitochondrial and nuclear fractions from HeLa cells and examined whether endogenous Sirt3 were present in these fractions by Western blotting using antibodies that target the *C*-terminal (from Cell signaling) and the *N*-terminal (from D. Reinberg lab) regions of Sirt3, respectively. Consistent with the literature, while the short-form Sirt3 were identified in the mitochondrial fraction exclusively, we indeed detected full-length Sirt3 in the nuclear fraction (see [Figure 5--figure supplement 3b](#fig5s3){ref-type="fig"}). Furthermore, using anti-Sirt3 (*N*-term) antibody, we were also able to show that Sirt3 indeed localize in the nucleus of the HeLa cells using IF (see [Figure 5--figure supplement 3a](#fig5s3){ref-type="fig"}). In addition, another line of evidence that supports the nuclear localization of Sirt3 came from our chromatin immunoprecipitation (ChIP) type of experiments. As mentioned above, Sirt3 was found to localize to a broad variety of genomic regions (see reference 12 in the table above). We therefore focused some of these regions and examined whether Sirt3 could regulate the lysine crotonylation (Kcr) levels on these regions. Our data showed that knockdown of Sirt3 indeed caused significant increase in Kcr levels of the tested genomic regions (see [Figure 5e](#fig5){ref-type="fig"}). This result will be further discussed in our response to the point \#4 raised by the reviewers.

Taken together, although Sirt3 was identified as the primary deacetylase in mitochondria and involved in metabolic regulation through controlling protein acetylation dynamics, it did not rule out the possibility that Sirt3 may play roles outside mitochondria. Indeed, both the literature review and our experimental data suggest that Sirt3 can be present and function in nucleus.

*2) A closely related question is the impact of Sirt1-3 knockdown/overexpression on histone acetylation and methylation (1, 2 and 3 Me) levels of H3K4. For instance, could the observed effects on crotonylation be caused by changes of other modifications at these sites in these proteins due to knockdown? These experiments would be straightforward and are critical to support the interpretation of the authors*.

We appreciate the reviewers' thoughtful comments. To rule out the possibility that the increase in the crotonylation level on histone H3K4 upon Sirt3 knockdown was caused by the changes of other modifications on the same site, we also examined the acetylation (H3K4Ac) and methylation (H3K4Me3) levels in the Sirt3 knockdown experiments. Our data showed that while the H3K4Cr level was significantly enhanced by Sirt3 knockdown, the H3K4Ac and H3K4Me3 levels remained unaltered, suggesting that Sirt3 indeed selectively targets histone crotonylation. We have now included this data in [Figure 5d](#fig5){ref-type="fig"}.

*3) A different important concern is the lack of quantitation with respect to the decrotonylation activity. The authors convincingly demonstrate that decrotonylation occurs in vitro and that O-crotonyl-ADPR is formed, but without any steady-state kinetic parameters it is unclear how robust (and hence meaningful) this activity is. Only physiologically relevant kinetic parameters would support a functional role of histone decrotonylation*.

We agree with the reviewers that the steady-state kinetic parameters are important to this newly identified decrotonylase. In the revised manuscript (see [Figure 5--figure supplement 3b](#fig5s3){ref-type="fig"} in the revised manuscript), we determined the *k*~*cat*~ (0.01 s^-1^)*, K*~*m*~ (12.6 μM)*, and k*~*cat*~*/K*~*m*~ (7.83 × 10^2^ s^-1^M^-1^) values for Sirt3's decrotonylase activity using H3K4Cr as the substrate. These values are comparable to the steady-state kinetic parameters for some recently identified deacylases, such as Sirt5 as demalonylase and desuccinylase, and Sirt6 as de-long-chain fatty acylase (e.g., demyristoylase). Therefore, we believe the decrotonylase activity of Sirt3 is robust.

*4) The biological consequences (and therefore importance) of decrotonylation activity are currently not clear. Given the apparent selectivity for histones (based on* [*Figure 5a*](#fig5){ref-type="fig"}*), a relatively straightforward first look would involve analysis of transcriptional changes upon knockdown of Sirt3. RNA-seq with H3K4Cr Chip-Seq, or alternatively focusing on a few loci and examining potential correlations of H3K4Cr (Chip-PCR) upon Sirt3 knockdown, would provide important information*.

We appreciate the reviewers' helpful comments and suggestions about the preliminary exploration of potential biological significance of (de)crotonylation. It has been reported that Sirt3 can bind to chromatin and cause the repression of the neighboring genes in U2OS cells. We therefore hypothesized that Sirt3 could regulate the gene transcription via controlling the local histone Kcr levels. To test this hypothesis, we focused on seven candidate genes, *Baz2a*, *Brip1*, *Corin*, *Ptk2*, *Tshz3*, *Wapal* and *Zfat*, whose transcription start sites (TSS) are close to Sirt3 enriched region. Chromatin precipitation (ChIP) coupled with quantitative PCR (qPCR) was performed in U2OS cells with the pan anti-Kcr antibody to measure the Kcr levels near TSS of the candidate genes. We found that Sirt3 knockdown by siRNA resulted in significant increases in the Kcr levels of five of the seven genes analyzed, indicating that Sirt3 may directly regulate crotonylation dynamics at the genomic loci where it binds to (see [Figure 5e](#fig5){ref-type="fig"}). Interestingly, the mRNA levels of the three candidate genes with increased Kcr levels, *Ptk2*, *Tshz3* and *Wapal*, were also significantly up-regulated upon Sirt3 knockdown (see [Figure 5f](#fig5){ref-type="fig"} ). Given that histone Kcr is enriched at active gene promoters and potential enhancers, this positive correlation between the gene transcription level and the nearby histone Kcr level upon Sirt3 knockdown suggests that Sirt3 might relieve a repressive effect on these target genes through 'erasing' histone Kcr 'marks'. To examine this correlation genome-wide requires comprehensive profiling of global histone Kcr and gene expression regulated by Sirt3 using ChIP couple to high-throughput sequencing (ChIP-seq), in combination with RNA sequencing (RNA-seq) in future studies.

In addition, same type of PTM at different modification sites of histones may have distinct effects on gene expression. For example, trimethylation at histone H3 Lys-4 (H3K4Me3) 'marks' genes that are being actively transcribed, whereas the same modification at H3 Lys-27 (H3K27Me3) 'marks' transcriptionally silent chromatin. By analogy, it is possible that crotonylation at specific lysine sites of histones could also play different roles in the regulation of gene expression. The study of the effects of site-specific histone Kcr 'marks' (e.g., H3K4Cr) targeted by Sirt3 on the regulation of gene expression is an important next step. Unfortunately, in our preliminary ChIP-qPCR study, we found that the only commercial available antibody that target H3K4Cr (from PTM BioLabs) is not suitable for ChIP experiments (the immune-precipitated chromatin was less than 0.1% of input). Therefore, new antibodies for this purpose need to be developed in future studies.

*5) The structural studies of crotonylated peptide to SIRT3 propose a binding mode involving Phe180 that is highly conserved. What is not mentioned is that this residue is known to interact strongly with NAD in prior structural work (e.g. Wolbergers comprehensive studies, which include termolecular structures of both NAD and peptides bound to sirtuin active sites). The authors state that this residue is not conserved in SIRT4-7, but its identification and conservation has been supported by many sequence comparison and structural studies. The observed lack of decrotonylation activity upon mutation may therefore be a consequence of disrupted NAD binding rather than demonstrating substrate selectivity. It also questions whether the observed binding mode in the absence of NAD is relevant if NAD is bound to the enzyme. Steady state parameters for the decrotonylation activity of the mutant and binding studies of NAD and the crotonylated peptide to the mutant may be able to address these concerns*.

We thank the reviewers for this thoughtful comment. Indeed, Wolberger's studies revealed that an invariant Phe33 in Sir2Tm (conserved in sirtuins and corresponding to human Sirt3 Phe157 rather than Phe180) strongly interacts with NAD. To the best of our knowledge, the interaction between Phe180 of Sirt3 and NAD have not been described. In our crystal structure of Sirt3-H3K4Cr complex, Phe180 is involved in recognition of crotonyl lysine via π−π stacking interaction. To further examine the importance of this conserved phenylalanine to the enzymes' decrotonylase activity, we mutated Phe180 of Sirt3 to a leucine residue, which lacks an aromatic ring as a π-donor but remains a similar hydrophobicity. We then carried out kinetic studies on this F180L mutant Sirt3. The steady-state kinetics data showed that the catalytic efficiency of Sirt3 F180L mutant (*k*~cat~/*K*~m~ = 21 s^-1^ M^-1^) for the hydrolysis of the H3K4Cr peptide was about 40-fold lower than that of wild-type Sirt3 (*k*~cat~/*K*~m~ = 783 s^-1^ M^-1^) (see [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}), indicating a critical role of the phenylalanine-mediated π−π interaction in the enzymes' decrotonylation activity. Interestingly, the F180L mutation caused only around 2-fold decrease in the enzyme's deacetylation activity (see [Figure 4--figure supplement 6](#fig4s6){ref-type="fig"}). This result rules out the possibility that the observed significant decrease in the enzyme's decrotonylase activity is caused by a potential disruption of the NAD-binding pocket in the mutated Sirt3.

[^1]: These authors contributed equally to this work.
